Pain Medicine News, the premier trade publication in the pain management space ... was associated with less use of opioid analgesics in patients with neuropathic pain compared with the 5% lidocaine ...

New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

Some other medicines that are slated to become blockbusters in the near future include GSK’s vaccine candidate GSK-3536819 ...

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

In an era of escalating healthcare costs, Americans increasingly face crucial decisions about their prescription medications. The choice between generic and brand-name drugs represents a ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...

Generally, paralytic drugs are administered for the duration of surgery, which can last for less than half an hour or up to several hours, depending on the procedure. If you are having a paralytic ...

The new drug development program - XRx-026 - will focus on the ... At XORTX, we are dedicated to developing medications to improve the quality of life and health of kidney disease patients and ...

Objective Macrophage activation by monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals mediates an interleukin (IL)-1β-dependent inflammation during gout and pseudo-gout flare, ...

Gout Gout has ripped up the record books and earned inevitable comparisons with Usain Bolt. But after the teenage sprinter last month became a global sensation with his performances at the ...

Nearly all of the drug price increases are below 10% — most well below. The median price increase of the drugs being hiked Jan. 1 is 4.5%, which is in line with the median for all price ...